VICTOZA INJ 1 unit

Victoza Solution 

Victoza Solution is an anti-diabetic medication that is primarily used to treat type 2 diabetes mellitus in children and adults over the age of ten years. Diabetes mellitus is a metabolic disorder characterized by abnormally elevated blood sugar levels. Type 2 diabetes develops when the pancreas’s hormone for lowering blood glucose, ‘insulin,’ is secreted but is unable to be used by our body’s cells to produce energy.

Victoza Solution contains Liraglutide, a recombinant Deoxyribonucleic Acid (rDNA) that acts by increasing pancreatic insulin release during periods of elevated blood sugar (post-meal) and decreasing the amount of sugar produced by the liver. Additionally, Victoza Solution decreases stomach emptying, which suppresses hunger and helps weight loss in an individual.

Victoza Solution is injected subcutaneously, or beneath the skin (SC). Nausea, vomiting, diarrhea, decreased appetite, stomach trouble, constipation, headache, tiredness, rash, and dizziness are some of the more typical side effects of Victoza Solution. These adverse effects are not universal and vary by individual. Consult your doctor if you have any uncontrollable adverse effects.

Before beginning Victoza Solution, inform your doctor if you have a history of heart, kidney, or liver problems, pancreatitis (pancreas inflammation), or stomach abnormalities such as gastroparesis (delayed gastric emptying). Do not take or discontinue this medication unless your doctor has advised you to do so. Use Victoza Solution in conjunction with prandial insulin is not recommended (mealtime insulin). It is recommended that you avoid alcohol while using Victoza Solution to avoid further low blood sugar levels. Consult your doctor before beginning Victoza Solution if you are pregnant or breastfeeding.

Victoza Solution Indications and Uses Type 2 diabetes mellitus

Medicinal Advantages

Victoza Solution includes the active ingredient ‘Liraglutide’ and is used to treat type 2 diabetes mellitus. It is a recombinant DNA (rDNA) that acts similarly to a naturally occurring hormone called Incretin (metabolic hormone, which stimulates a decrease in blood glucose levels). It works by enhancing pancreatic insulin secretion during periods of elevated blood sugar (after a meal) and decreasing the amount of sugar produced by the liver. Victoza Solution may be prescribed in conjunction with or in lieu of other drugs, as well as diet and exercise, to help regulate blood sugar levels.

Use Instructions

Victoza Solution is injected beneath the skin. Your doctor will determine the dosage based on the severity of your disease and your tolerance. Your doctor may begin with a low dose and gradually increase it to a level that achieves the desired blood glucose control. Victoza Solution injectable solution should be clear, colorless, and particle-free. Subcutaneously (under the skin) inject Victoza Solution into the abdomen, thigh, or upper arm. Victoza Solution may be taken with or without food. Victoza Solution should be taken with food, as it decreases blood sugar and may produce gastrointestinal adverse effects. Refrigerate or store at room temperature the Victoza Solution pen and use within 30 days. Victoza Solution should not be frozen.

Storage Keep out of direct sunlight and in a cool, dry area.

Victoza Solution Adverse Reactions

Nausea

Vomiting

Diarrhea

Appetite reduction

Discomfort in the stomach Constipation

Headache

Rash is exhausted.

Dizziness

Adverse Drug Reactions

Before beginning Liraglutide, inform your doctor if you have any heart, kidney, or liver disease, pancreatitis (pancreas inflammation), stomach abnormalities such as gastroparesis (slow gastric emptying), excessive cholesterol levels, gallbladder difficulties, or depression. Liraglutide is contraindicated in patients with type 2 multiple endocrine neoplasia (thyroid and parathyroid gland tumors) and a personal or family history of thyroid cancer. Avoid concomitant use of Liraglutide and prandial insulin (mealtime insulin). Take Liraglutide and insulin injections separately if you are also taking insulin. Kindly do not combine them. Both injections can be administered in the same body location, but the injection sites should not be adjacent to one another. Sharing an injectable pen, cartridge, or syringe with another person is not permitted, even if the needle has been replaced. It is recommended that you avoid alcohol while taking Liraglutide to avoid further low blood sugar levels. Women who are pregnant or breastfeeding should consult their physician before beginning this drug. Liraglutide should be used only in children and adults over the age of ten.

Interactions Between Drugs

Liraglutide may interact with other anti-diabetic medications (insulin glargine, insulin degludec), hormones (levothyroxine), corticosteroids (prednisone), antipsychotic medications (olanzapine), antibiotics (ciprofloxacin), hypertension medications (propranolol, metoprolol), and glaucoma eye drops (timolol).

Alcohol consumption should be limited due to its effect on blood sugar levels. Avoid greasy foods and increase your intake of nutritious carbs.

Before taking Liraglutide, inform your doctor if you have a history of allergic reactions to medications, heart, kidney, or liver disease, pancreatitis (pancreas inflammation), stomach disorders such as gastroparesis (delayed gastric emptying), high cholesterol levels, gallbladder problems, or depression. Liraglutide is contraindicated in patients with type 2 multiple endocrine neoplasia (thyroid and parathyroid gland tumors) and a personal or family history of thyroid cancer.

Safety Recommendations

ALCOHOL

It is recommended to restrict alcohol consumption because it may exacerbate adverse effects and raise the chance of developing hypoglycemia.

PREGNANCY

Liraglutide was found to be toxic to the foetus in animal tests. Liraglutide should be used during pregnancy only if the benefit outweighs the risk. Consult your physician before to initiating Liraglutide if you are pregnant or planning to become pregnant.

BREAST FEEDING

There is insufficient data on the effect of Liraglutide on breastfeeding. If you are lactating, it is prudent to obtain medical counsel prior to initiating Liraglutide.

DRIVING

If your blood sugar levels are too high or too low, it may impair your driving. Avoid driving or operating machinery if you have blurred vision, dizziness, or drowsiness as a result of severely low or high blood sugar.

LIVER

When taking Liraglutide, inform your doctor if you have a history of liver illness or hepatic impairment.

KIDNEY

When taking Liraglutide, inform your doctor if you have a history of kidney illness.

No.

Advice on Diet and Lifestyle

Take the medication exactly as your doctor has prescribed and at regular intervals if you are taking Liraglutide more than once per day. When using Liraglutide, do not use any additional over-the-counter drugs, herbal supplements, or vitamin supplements without first consulting your pharmacist or doctor.

Consume a high-fiber diet rich in fruits, vegetables, and whole grains to help control your blood glucose levels.

Consume food at regular intervals.

Maintain a healthy weight and engage in regular exercise to keep your heart healthy.

Additionally, your doctor will educate you on how to recognize and manage the early symptoms of high/low blood sugar levels.

Simple lifestyle changes can help manage gastrointestinal side effects. These include a reduction in sugar and fatty foods, as well as an avoidance of carbonated beverages and foods that induce gas.

Special Guidance

Liraglutide may increase the chance of thyroid gland tumor development, particularly medullary thyroid carcinoma (MTC – a type of thyroid cancer).

Never reuse insulin needles or exchange insulin pens or needles.

Additionally, this item is non-returnable.

Concern for Patients

Diabetes mellitus, also referred to as adult-onset diabetes, is a metabolic disorder characterized by elevated blood sugar levels. It is a type 2 diabetes that arises when insulin (a hormone produced by the pancreatic’s beta cells) is ineffective in breaking down glucose to produce energy (insulin resistance) or when the pancreas (an organ beneath the stomach) produces insufficient or no insulin. This condition is more prevalent in persons over the age of 40, but it can also occur in children, depending on the risk factors. Treatment consists of oral glucose-lowering medications and insulin injections.

FAQs

Victoza Solution contains Liraglutide, which stimulates the pancreas to release more insulin after meals when your blood glucose levels are elevated. Thus, Liraglutide aids in the reduction of blood sugar levels in patients with type 2 diabetes mellitus.

Liraglutide may cause hypoglycemia, which can make you feel hungry, dizzy, irritable, confused, worried, or shaky. As a result, it is recommended to take Liraglutide with food. To cure hypoglycemia quickly, it is recommended to consume or consume fast-acting sugar sources such as fruit juices, hard candy, raisins, or non-diet cola.

Liraglutide injectable solution should be used only if it is clear, colorless, and particle-free. Subcutaneously (under the skin) inject Liraglutide into the abdomen, thigh, or upper arm. Liraglutide may be taken with or without food. However, Liraglutide should be taken with food if possible, as it decreases blood sugar levels and may produce gastrointestinal adverse effects. Sharing an injectable pen, cartridge, or syringe with another person is not permitted, even if the needle has been replaced.

Liraglutide may be prescribed alone or in combination with other drugs to help control your blood sugar levels. However, it is recommended to avoid using Liraglutide in conjunction with prandial insulin (mealtime insulin). Take Liraglutide and insulin injections separately if you are also taking insulin. Kindly do not combine them. Both injections can be administered in the same body location, but the injection sites should not be adjacent to one another.

Liraglutide should be taken cautiously in patients with heart, kidney, or liver disease, pancreatitis (pancreatic inflammation), stomach abnormalities such as gastroparesis (slow gastric emptying), hypercholesterolemia, gallbladder difficulties, or depression. Liraglutide is contraindicated in patients with type 2 multiple endocrine neoplasia (thyroid and parathyroid gland tumors) and a personal or family history of thyroid cancer.

As soon as feasible, take the missed dose. If, however, the next dose is approaching, skip the missing dose and resume your regular dosing plan. Contrary to popular belief, do not double the dose.

Refrigerate any unused Liraglutide pens between 2°C and 8°C. Liraglutide should be stored at a room temperature of 15°C to 30°C or in the refrigerator after initial use and used within 30 days. Liraglutide should not be frozen. Liraglutide should not be used if it has been frozen.